Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.80 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.80 |
| ▸ | RELA | Q04206 | 2/20 | 0.80 |
| ▸ | SLC5A1 | P13866 | 7/20 | 0.77 |
| ▸ | SLC5A2 | P31639 | 7/20 | 0.77 |
| ▸ | GAA | P10253 | 4/20 | 0.77 |
| ▸ | MAPT | P10636 | 2/20 | 0.77 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | CBS | P35520 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | SLC16A3 | O15427 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28968230 | 0.93 | NFKB1 (0.69) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL29435841 | 0.91 | NFKB1 (0.68) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL1937964 | 0.91 | NFKB1 (0.68) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| Asebogenin SCHEMBL4740064 | 0.89 | NFKB1 (0.88) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL5084404 | 0.89 | NFKB1 (1.00) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL455029 | 0.87 | SLC5A1 (1.00) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL15457885 | 0.86 | NFKB1 (0.83) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL1938569 | 0.85 | SLC5A1 (0.73) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL28968233 | 0.85 | NFKB1 (0.59) | NFKB1NFKB2RELASLC5A1SLC5A2 | |
| SCHEMBL17502354 | 0.84 | RAB9A (0.60) | NFKB1NFKB2RELASLC5A1SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10695283-B2 | Extract of Greyia radlkoferi and use thereof | UNIVERSITY OF PRETORIA (ZA) | 2020-06-30 | — | — | US | claimed |
| US-20180071204-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF KWAZULU-NATAL (ZA) | 2018-03-15 | — | — | US | claimed |
| EP-2849768-B1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIV PRETORIA (ZA) | 2016-06-01 | — | — | EP | claimed |
| US-20150118337-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2015-04-30 | — | — | US | claimed |
| CN-122005634-A | Compound antibacterial gel of herba Pileae Scriptae, and preparation method and application thereof | 贵州盛世泰合医药科技有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2026-03-10 | — | — | US | disclosed |
| US-12453799-B1 | Bioadhesive for medical and dental applications | IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY (SA) | 2025-10-28 | — | — | US | disclosed |
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-08-07 | — | — | US | disclosed |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2025-06-03 | — | — | US | disclosed |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY (SA) | 2024-09-05 | — | — | US | disclosed |
| EP-4403042-A2 | FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | Mars, Incorporated (US) | 2024-07-24 | — | — | EP | disclosed |
| EP-3229612-B1 | USE OF FLAVOR COMPOSITIONS AND PET FOOD PRODUCTS CONTAINING THE SAME | MARS INC (US) | 2024-06-26 | — | — | EP | disclosed |
| US-20150118337-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2015-04-30 | — | — | US | disclosed |
| CN-104582713-A | Grignard family feijie extract and application thereof | UNIV PRETORIA | 2015-04-29 | — | — | CN | disclosed |
| EP-2849768-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | University of Pretoria (ZA) | 2015-03-25 | — | — | EP | disclosed |
| EP-2849768-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | University of Pretoria (ZA) | 2015-03-25 | — | — | EP | disclosed |
| US-20140023721-A1 | METHOD OF EXTRACTING ACTIVE MOLECULES FROM NATURAL RESINS AND USE THEREOF | RODE PHARMA S.R.L. (IT) | 2014-01-23 | — | — | US | disclosed |
| WO-2013171720-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2013-11-21 | — | — | WO | disclosed |
| WO-2013171720-A1 | EXTRACT OF GREYIA RADLKOFERI AND USE THEREOF | UNIVERSITY OF PRETORIA (ZA) | 2013-11-21 | — | — | WO | disclosed |
| WO-2008100977-A2 | CARBAMATES THERAPEUTIC RELEASE AGENTS AS AMIDASE INHIBITORS | N.V. ORGANON (NL) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250249063-A1 | METHOD FOR TREATING ORAL CANCER | UGGT1, G6PD, UGT1A3 | NFKB1 1450/4885NFKB2 2221/4885RELA 414/4885 |
| US-20240293492-A1 | TANNIN-BASED ANTIPROLIFERATIVE PHARMACEUTICAL | UGGT1, G6PD, UGDH | NFKB1 684/4885NFKB2 1141/4885RELA 425/4885 |
| US-12569530-B2 | Tannin-based antiproliferative pharmaceutical | SLC2A3, SLC2A1, SLC2A8 | NFKB1 892/4885NFKB2 949/4885RELA 542/4885 |
| US-12318422-B2 | Tannin-based antiproliferative pharmaceutical | UGGT1, G6PD, UGDH | NFKB1 684/4885NFKB2 1141/4885RELA 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.